Filing Details
- Accession Number:
- 0000919574-22-005788
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-05 16:24:22
- Reporting Period:
- 2022-10-03
- Accepted Time:
- 2022-10-05 16:24:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1287098 | Maxcyte Inc. | MXCT | Services-Commercial Physical & Biological Research (8731) | 522210438 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534260 | Casdin Partners Gp, Llc | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No | |
1534261 | Casdin Capital, Llc | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No | |
1534264 | Eli Casdin | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No | |
1534265 | Casdin Partners Master Fund, L.p. | 1350 Avenue Of The Americas Suite 2600 New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Disposition | 2022-10-03 | 735,786 | $6.15 | 10,000,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- (1) The securities are owned directly by Casdin Partners Master Fund, LP (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.